Buscar resultados de ensayos clínicos
Primary Myelofibrosis - 26 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis Condición:
|
Completed |
Nombre del estudio: A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis Condición: Myelofibrosis Fecha: 2008-07-17 Intervenciones: Drug: SAR302503 (TG101348) orally administered, once a day |
Completed |
Nombre del estudio: Study of Ruxolitinib (INCB018424) Sustained Release Formulation in Myelofibrosis Patients Condición: Myelofibrosis Fecha: 2011-04-21 Intervenciones: Drug: Ruxolitinib Ruxolitinib was supplied as SR and IR formulated tablets. |
Recruiting |
Nombre del estudio: Interferon-pegyle α2a Efficiency and Tolerance in Myelofibrosis Condición: Myelofibrosis Fecha: 2016-08-26 |
Active, not recruiting |
Nombre del estudio: Lenalidomide for Patients With Myelofibrosis (MF) Condición: Myelofibrosis Fecha: 2006-07-14 Intervenciones:
|
Completed |
Nombre del estudio: A Clinical Study of Ruxolitinib in Patients With Primary Myelofibrosis (PM), Post-polycythemia Vera (PV) Myelofibrosis, or Post-essential Thrombocythemia (ET) Myelofibrosis Condición: Primary Myelofibrosis (MF) Fecha: 2014-03-12 Intervenciones: Drug: Ruxolitinib |
Active, not recruiting |
Nombre del estudio: JAK2 Inhibitors RUXOLITINIB in Patients With Myelofibrosis Condición: Myelofibrosis Fecha: 2012-12-21 Intervenciones: Drug: Ruxolotinib Ruxolotinib doses calculated with platelets count and P450 cytochrome inhibitor HSCT f |
Active, not recruiting |
Nombre del estudio: Panobinostat and Ruxolitinib In MyElofibrosis (PRIME Trial) Condición: Myelofibrosis Fecha: 2012-09-14 Intervenciones:
|
Recruiting |
Nombre del estudio: Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis Condición: Myelofibrosis Fecha: 2016-09-30 Intervenciones: Other: Hematopoietic Stem Cell Transplant This observational study will compare outcomes of prospectivel |
Recruiting |
Nombre del estudio: JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis Condición:
|